Captrust Financial Advisors Ngm Biopharmaceuticals Inc Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $856 - $1,153	-62 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $2,571 - $3,280	-149 Reduced 70.62%	62 $1,000
Q3 2021 Nov 16, 2021	BUY	$20.15 - $26.19 $2,276 - $2,959	113 Added 115.31%	211 $4,000
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $30 - $60	2 Added 2.08%	98 $2,000
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $2,399 - $3,065	96 New	96 $3,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.